These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

902 related articles for article (PubMed ID: 34053447)

  • 1. Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers.
    Liu Y; Teng L; Fu S; Wang G; Li Z; Ding C; Wang H; Bi L
    BMC Cancer; 2021 May; 21(1):644. PubMed ID: 34053447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulated cyclins may be novel genes for triple-negative breast cancer based on bioinformatic analysis.
    Lu Y; Yang G; Xiao Y; Zhang T; Su F; Chang R; Ling X; Bai Y
    Breast Cancer; 2020 Sep; 27(5):903-911. PubMed ID: 32338339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel biomarkers identified in triple-negative breast cancer through RNA-sequencing.
    Chen YL; Wang K; Xie F; Zhuo ZL; Liu C; Yang Y; Wang S; Zhao XT
    Clin Chim Acta; 2022 Jun; 531():302-308. PubMed ID: 35504321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of key genes as potential biomarkers for triple‑negative breast cancer using integrating genomics analysis.
    Zhong G; Lou W; Shen Q; Yu K; Zheng Y
    Mol Med Rep; 2020 Feb; 21(2):557-566. PubMed ID: 31974598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer.
    Qiu P; Guo Q; Yao Q; Chen J; Lin J
    PLoS One; 2021; 16(11):e0254283. PubMed ID: 34797837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A ten N6-methyladenosine-related long non-coding RNAs signature predicts prognosis of triple-negative breast cancer.
    Wu J; Cai Y; Zhao G; Li M
    J Clin Lab Anal; 2021 Jun; 35(6):e23779. PubMed ID: 33934391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer.
    Fan CN; Ma L; Liu N
    J Cell Biochem; 2019 Mar; 120(3):3185-3196. PubMed ID: 30203490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8
    Li J; Yao J
    Mol Med Rep; 2024 Sep; 30(3):. PubMed ID: 39027992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
    Zhai Q; Li H; Sun L; Yuan Y; Wang X
    Breast Cancer; 2019 Nov; 26(6):784-791. PubMed ID: 31197620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening and identification of potential biomarkers in triple-negative breast cancer by integrated analysis.
    Guo J; Gong G; Zhang B
    Oncol Rep; 2017 Oct; 38(4):2219-2228. PubMed ID: 28849078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identified the novel resistant biomarkers for taxane-based therapy for triple-negative breast cancer.
    Chou CW; Huang YM; Chang YJ; Huang CY; Hung CS
    Int J Med Sci; 2021; 18(12):2521-2531. PubMed ID: 34104083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated network analysis and machine learning approach for the identification of key genes of triple-negative breast cancer.
    Naorem LD; Muthaiyan M; Venkatesan A
    J Cell Biochem; 2019 Apr; 120(4):6154-6167. PubMed ID: 30302816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of dysregulated microRNAs associated with diagnosis and prognosis in triple‑negative breast cancer: An in silico study.
    Fan C; Liu N
    Oncol Rep; 2019 Jun; 41(6):3313-3324. PubMed ID: 30942465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA-135b Contributes to
    Uva P; Cossu-Rocca P; Loi F; Pira G; Murgia L; Orrù S; Floris M; Muroni MR; Sanges F; Carru C; Angius A; De Miglio MR
    Int J Med Sci; 2018; 15(6):536-548. PubMed ID: 29725243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive characterization of stemness-related lncRNAs in triple-negative breast cancer identified a novel prognostic signature related to treatment outcomes, immune landscape analysis and therapeutic guidance: a silico analysis with in vivo experiments.
    Zhang M; Zhang F; Wang J; Liang Q; Zhou W; Liu J
    J Transl Med; 2024 May; 22(1):423. PubMed ID: 38704606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCC9, NKAPL, and TMEM132C are potential diagnostic and prognostic markers in triple-negative breast cancer.
    Zhang X; Kang X; Jin L; Bai J; Zhang H; Liu W; Wang Z
    Cell Biol Int; 2020 Oct; 44(10):2002-2010. PubMed ID: 32544280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer.
    Liu YR; Jiang YZ; Xu XE; Yu KD; Jin X; Hu X; Zuo WJ; Hao S; Wu J; Liu GY; Di GH; Li DQ; He XH; Hu WG; Shao ZM
    Breast Cancer Res; 2016 Mar; 18(1):33. PubMed ID: 26975198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Hub Genes to Regulate Breast Cancer Spinal Metastases by Bioinformatics Analyses.
    He Y; Cao Y; Wang X; Jisiguleng W; Tao M; Liu J; Wang F; Chao L; Wang W; Li P; Fu H; Xing W; Zhu Z; Huan Y; Yuan H
    Comput Math Methods Med; 2021; 2021():5548918. PubMed ID: 34055036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene regulatory pattern analysis reveals essential role of core transcriptional factors' activation in triple-negative breast cancer.
    Min L; Zhang C; Qu L; Huang J; Jiang L; Liu J; Pinello L; Yuan GC; Shou C
    Oncotarget; 2017 Mar; 8(13):21938-21953. PubMed ID: 28423538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined mRNAs and clinical factors model on predicting prognosis in patients with triple-negative breast cancer.
    Hu Y; Zou D
    PLoS One; 2021; 16(12):e0260811. PubMed ID: 34965257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.